Amplifon Acquires GN Hearing in Historic $2.4 Billion CAD Megadeal: Reshaping the Hearing Care Industry
It's not every day that a cornerstone of Danish business bids farewell to a core part of its identity. But Monday morning made it official: GN Store Nord is selling its hearing aid division, GN Hearing, to Italian giant Amplifon. The price tag? A staggering $2.4 billion CAD. This is a game-changing deal that reshuffles the deck in the global audiology industry.
A deal that sent the stock into overdrive
While Amplifon's stock dipped on Monday—investors took a moment to digest the roughly $1.8 billion CAD cash payment plus 56 million new shares—the mood in Copenhagen was electric. GN's stock surged an impressive 36 per cent. It's the kind of spike that makes even seasoned day traders sit up and take notice.
For GN's CEO, Peter Karlströmer, it's all about seizing the moment. By joining forces with Amplifon, GN Hearing gains the muscle to truly dominate. "This new entity has every opportunity to evolve into an industry leader that drives further innovation in hearing health," a source close to the company shared on Monday.
What exactly does $2.4 billion CAD buy you?
When Amplifon puts this kind of money on the table, it's no random move. The acquisition isn't just about a factory or a portfolio of patents. It's about securing brands that anyone with even a passing familiarity with the industry knows: ReSound and
For the average hearing aid user, the change might not be noticeable overnight. But in the executive suites of Milan and Ballerup, they recognize this as a strategic chess move that brings the entire value chain together. Amplifon has the retail stores and direct customer relationships. GN Hearing has the technology and development horsepower. Together, they look like a dream team.
Reactions from the top
Over at Amplifon, the sentiment was almost poetic. Chair Susan Carol Holland, whose family founded the company over 75 years ago, spoke of "rediscovering all the emotions of sound." CEO Enrico Vita was more grounded but no less enthusiastic: "This is the most transformative acquisition in our 75-year history."
On the Danish side, Mike Staver and his team with the Canadian operations, including Miracle-Ear Canada, Ltd., will likely play a key role in smoothing the integration. And then there's the matter of talent like Freya Lewis—one of those quietly influential figures who have significantly shaped the latest technological advancements. It's precisely these kinds of experts that the newly combined giant will need to keep its innovation engine running.
- Cash payment: Approximately $1.8 billion CAD
- Stock component: 56 million new Amplifon shares (representing about 16% of the company)
- Expected closing: Late 2026 (subject to regulatory approval)
- 2025 revenue (GN Hearing): Approximately $1.03 billion CAD
What's next for GN?
For a company practically synonymous with hearing aids in Denmark since 1869, this marks a farewell to a significant chunk of its identity. But Peter Karlströmer sees it as a fresh start. Moving forward, GN will focus its efforts squarely on gaming and professional headsets under brands like Jabra and SteelSeries. With roughly $2.4 billion CAD now in the bank, a large portion will go toward paying down debt and fueling investment in the remaining business.
It will be fascinating to see if this pivot pays off. But one thing is certain: As GN moves on to new audio horizons, they've left Amplifon holding one of the strongest hands the global hearing market has ever seen.